COMMUNIQUÉS West-GlobeNewswire
-
BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics
16/05/2024 - 14:00 -
Halo Dental Technologies Opens Waitlist for Its New Digital Mirror at California Dental Association Annual Conference
16/05/2024 - 14:00 -
Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
16/05/2024 - 14:00 -
Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 23, 2024
16/05/2024 - 14:00 -
Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
16/05/2024 - 14:00 -
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease
16/05/2024 - 14:01 -
Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
16/05/2024 - 14:01 -
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Data Access
16/05/2024 - 14:05 -
NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International Cell & Gene Therapy China Summit & Exhibition
16/05/2024 - 14:05 -
Claritas HealthTech Extends Claritas iPET™ capability with iPETcertum™ for Automated Lesion Detection and Quantification of Isotope Uptake in PET Scans
16/05/2024 - 14:15 -
GLUCOTRACK’S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY
16/05/2024 - 14:30 -
Assure Announces Approval of Increase in Authorized Capital at Adjourned Special Shareholders Meeting
16/05/2024 - 14:30 -
Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Gender Policy Council
16/05/2024 - 14:30 -
May 2024 Letter to Shareholders
16/05/2024 - 14:30 -
Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference
16/05/2024 - 14:30 -
Council on Radionuclides and Radiopharmaceuticals, Inc. Supports House Committee on Foreign Affairs on Actions to Reduce U.S. Reliance on Russian Nuclear Material
16/05/2024 - 14:30 -
Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)
16/05/2024 - 14:30 -
ProSomnus Announces Strong First Quarter 2024 Revenue Growth
16/05/2024 - 14:42 -
Brain Cancer Canada Awards Grant for Innovative Medical Avatar Technology to Improve Treatments in High Grade Gliomas like Glioblastoma
16/05/2024 - 14:45
Pages